Information:
Fel:
ID
36608
Beskrivning
Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02256852
Länk
https://clinicaltrials.gov/show/NCT02256852
Nyckelord
Versioner (1)
- 2019-05-26 2019-05-26 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
26 maj 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Non-Small Cell Lung Cancer NCT02256852
Eligibility Non-Small Cell Lung Cancer NCT02256852
- StudyEvent: Eligibility
Similar models
Eligibility Non-Small Cell Lung Cancer NCT02256852
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
male or female who is at or above the age of consent
boolean
C0001779 (UMLS CUI [1])
Carcinoma of lung
Item
histologically confirmed original diagnosis of lung cancer
boolean
C0684249 (UMLS CUI [1])
Life Expectancy
Item
life expectancy greater than 12 months
boolean
C0023671 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0, 1, or 2 at screening
boolean
C1520224 (UMLS CUI [1])
Gender Contraceptive methods Quantity
Item
female subjects who agree to practice two effective methods of contraception from the time of signing the informed consent form through one month after the last dose of study drug
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0700589 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Gender Barrier Contraception
Item
male subjects who agree to practice effective barrier contraception during the entire study drug period and through one month after the last dose of study drug
boolean
C0079399 (UMLS CUI [1,1])
C0004764 (UMLS CUI [1,2])
C0004764 (UMLS CUI [1,2])
Carcinoma of lung Progression | Exception Thoracic region
Item
extra-thoracic lung cancer progression
boolean
C0684249 (UMLS CUI [1,1])
C0242656 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0817096 (UMLS CUI [2,2])
C0242656 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0817096 (UMLS CUI [2,2])
Malignant Neoplasms
Item
any active malignancies
boolean
C0006826 (UMLS CUI [1])
Organ dysfunction Uncontrolled | Dysfunction Organ Major
Item
any uncontrolled or major organ dysfunction
boolean
C0349410 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C3887504 (UMLS CUI [2,1])
C0178784 (UMLS CUI [2,2])
C0205164 (UMLS CUI [2,3])
C0205318 (UMLS CUI [1,2])
C3887504 (UMLS CUI [2,1])
C0178784 (UMLS CUI [2,2])
C0205164 (UMLS CUI [2,3])
Therapeutic radiology procedure Carcinoma of lung | Systemic therapy Carcinoma of lung
Item
any past or current radiation or systemic therapies for the treatment of lung cancer
boolean
C1522449 (UMLS CUI [1,1])
C0684249 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2,1])
C0684249 (UMLS CUI [2,2])
C0684249 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2,1])
C0684249 (UMLS CUI [2,2])
HIV Infection | Immunosuppression
Item
known hiv infection or other immunosuppressive disorder
boolean
C0019693 (UMLS CUI [1])
C4048329 (UMLS CUI [2])
C4048329 (UMLS CUI [2])
Study Subject Participation Status | Immunotherapy Investigational
Item
concurrently participating in another study with an investigational immunotherapy or have received investigational immunotherapy within 3 months prior to screening
boolean
C2348568 (UMLS CUI [1])
C0021083 (UMLS CUI [2,1])
C1517586 (UMLS CUI [2,2])
C0021083 (UMLS CUI [2,1])
C1517586 (UMLS CUI [2,2])